Industry ESG Benchmark 23 Tracked Equities
Pharmaceuticals ESG Stocks & Ratings
Pharmaceuticals — Industry on The Impact Investor | ESG Investing Blog
Tracked Equities23Active Listings
Avg ESG RatingAMSCI Benchmark
Data Freshness October 2026 Verified Monthly
Related Decision Tools
Sustainability Analysis & Growth Models
Estimate portfolio carbon intensity and compound ESG dividend growth.
Listed Companies in Pharmaceuticals
Showing page 1 of 2
| Company & Symbol | Exchange | Price | Day change | Quote state | MSCI ESG | Action |
|---|---|---|---|---|---|---|
|
AstraZeneca
A5
|
NYSE | N/A | — | Unavailable | — | |
| NYSE | $5.80 USD | up +1.22% | Last closeOct 2, 8:00 PM GMT+0000 | — | ||
|
Bayer
B10
|
NYSE | N/A | — | Unavailable | — | |
| NYSE | $61.15 USD | up +0.53% | Last closeOct 2, 8:00 PM GMT+0000 | 75.4 / 100 | ||
|
Catalent, Inc.
CTLT
|
NYSE | N/A | — | Unavailable | 72.7 / 100 | |
| NYSE | $22.14 USD | up +1.70% | Last closeOct 2, 8:00 PM GMT+0000 | — | ||
| NYSE | $1,142.85 USD | down -0.61% | Last closeOct 2, 8:00 PM GMT+0000 | A | ||
|
EMD Group
E4
|
NYSE | N/A | — | Unavailable | — | |
| NYSE | N/A | — | Unavailable | — | ||
| NYSE | $256.03 USD | down -1.02% | Last closeOct 2, 8:00 PM GMT+0000 | A | ||
| NYSE | N/A | — | Unavailable | — | ||
|
Merck & Co. Inc.
MRK
|
NYSE | $144.30 USD | up +0.34% | Last closeOct 2, 8:02 PM GMT+0000 | A | |
|
Novartis
N
|
NYSE | N/A | — | Unavailable | AA | |
|
Novo Nordisk
NN
|
NYSE | N/A | — | Unavailable | AAA | |
|
Nuvation Bio Inc.
NUVB
|
NYSE | $5.14 USD | down -7.55% | Last closeOct 2, 8:00 PM GMT+0000 | — | |
|
Organon & Co.
OGN
|
NYSE | $13.72 USD | up +0.07% | Last closeOct 2, 8:00 PM GMT+0000 | — | |
|
Perrigo Company plc
PRGO
|
NYSE | $14.26 USD | up +1.71% | Last closeOct 2, 8:00 PM GMT+0000 | — | |
|
Pfizer Inc.
PFE
|
NYSE | $27.80 USD | down -1.14% | Last closeOct 2, 8:01 PM GMT+0000 | A | |
| NYSE | $45.26 USD | up +1.09% | Last closeOct 2, 8:00 PM GMT+0000 | — | ||
|
Sanofi
SAN.PA
|
Euronext | N/A | — | Unavailable | A (Average) |
Pharmaceuticals Sustainability & Market Dynamics
Pharmaceuticals — Industry on The Impact Investor | ESG Investing Blog